How hENT1 Affects Drug Sensitivity in Childhood Leukemia
Author Information
Author(s): Hubeek I, Stam R W, Peters G J, Broekhuizen R, Meijerink J P P, Wering E R van, Gibson B E S, Creutzig U, Zwaan C M, Cloos J, Kuik D J, Pieters R, Kaspers G J L
Primary Institution: VU University Medical Center
Hypothesis
Decreased expression of hENT1 is a major factor in ara-C resistance in childhood acute myeloid leukaemia.
Conclusion
Reduced expression of hENT1, which transports ara-C across the cell membrane, is linked to drug resistance in childhood AML.
Supporting Evidence
- Lower hENT1 mRNA levels were found in resistant patients.
- Decreased hENT1 expression correlated with increased LC50 values for ara-C.
- Patients resistant to ara-C expressed three-fold lower hENT1 mRNA levels compared to sensitive patients.
Takeaway
Kids with leukemia might not respond well to a common drug because their cells don't let the drug in as easily. This study looks at why that happens.
Methodology
mRNA expression levels of key enzymes were measured using quantitative real-time PCR, and in vitro drug sensitivity was assessed using the MTT assay.
Limitations
The study included a limited number of samples and did not assess the relation between hENT1 expression and in vivo response to treatment.
Participant Demographics
{"sex_ratio":"31 male : 19 female","age_range":"0.1 to 16.8 years","FAB_types":{"M0":2,"M1":6,"M2":8,"M3":4,"M4":18,"M5":9,"unknown":3}}
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website